Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Mizuho analyst Uy Ear upgrades Relmada Therapeutics from Neutral to Outperform and raises the price target from $1 to $10.